Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026)

Verastem's (VSTM) quarterly Total Non-Current Liabilities came in at $146.0 million in Q1 2026, up 33.5% year-on-year from $109.4 million in Q1 2025, and down 4.93% quarter-over-quarter from $153.6 million in Q4 2025.

Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Verastem's Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $146.0 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 33.5% year-over-year to $146.0 million in Q1 2026; TTM through Mar 2026 was $146.0 million, a 33.5% increase from a year earlier, with the FY2025 full-year figure at $153.6 million, up 112.65% from the prior year.
  • Total Non-Current Liabilities declined to $146.0 million in Q1 2026 per VSTM's latest filing, from $153.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $153.6 million in Q4 2025 and bottomed at $68.0 million in Q3 2024.
  • The 4-year median for Total Non-Current Liabilities is $126.7 million (2025), against an average of $114.7 million.
  • Across the five-year window, Total Non-Current Liabilities decreased 5.21% in 2024 and surged 112.65% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $71.8 million in 2023, then advanced by 0.65% to $72.2 million in 2024, then jumped by 112.65% to $153.6 million in 2025, then retreated by 4.93% to $146.0 million in 2026.
  • Per Business Quant, the three latest VSTM Total Non-Current Liabilities figures stand at $146.0 million (Q1 2026), $153.6 million (Q4 2025), and $144.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn 146.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.03 Mn
Dec 31, 2025 153.60 Mn
Sep 30, 2025 144.09 Mn
Jun 30, 2025 152.66 Mn
Mar 31, 2025 109.39 Mn
Dec 31, 2024 72.23 Mn
Sep 30, 2024 68.02 Mn
Sep 30, 2023 71.76 Mn
Jun 30, 2020 83.29 Mn
Mar 31, 2020 84.30 Mn
Dec 31, 2019 137.00 Mn
Sep 30, 2019 170.21 Mn
Jun 30, 2019 168.73 Mn
Mar 31, 2019 154.41 Mn
Dec 31, 2018 151.81 Mn
Sep 30, 2018 74.98 Mn
Jun 30, 2018 45.65 Mn
Mar 31, 2018 29.76 Mn
Dec 31, 2017 31.96 Mn
Sep 30, 2017 21.95 Mn